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Abstract
Introduction: Radiation-induced nonmelanoma skin cancer was first reported seven years after the discovery of X-
rays, but has received relatively little consideration in the literature. Specifically, nonmelanoma skin cancer after 
conservative surgery and radiation for early stage breast cancer has not been well studied. We report the case of a 
woman who developed squamous cell carcinoma of the nipple nine years after conservative surgery and radiation for 
ductal carcinoma in situ of the ipsilateral breast. We also review the relevant literature available to date.
Case presentation: A 66-year-old African-American woman presented to the hospital with a non-healing ulcer of the 
right nipple. Her past medical history was significant for right breast ductal carcinoma in situ for which she had 
undergone lumpectomy and whole breast radiation therapy nine years previously. Mammography and magnetic 
resonance imaging studies were negative for recurrent breast cancer. However, the latter demonstrated abnormal 
enhancement in the nipple-areolar region. An incisional biopsy of the lesion demonstrated invasive squamous cell 
carcinoma. Subsequently, the patient underwent wide excision of the nipple-areolar complex. Sentinel lymph-node 
biopsy was offered but our patient declined. She was considered to have local disease and hence no further treatment 
was recommended.
Conclusion: This case represents the first reported occurrence of squamous cell carcinoma of the nipple to follow 
conservative surgery and radiation for ductal carcinoma in situ of the ipsilateral breast. It is likely that radiation 
overexposure resulted in a radiation burn and subsequent radiodermatitis, placing it at risk for squamous cell 
carcinoma. A diagnosis of squamous cell carcinoma should be considered in a patient with a nipple lesion following 
radiation therapy for breast cancer.
Introduction
Breast-conserving surgery followed by whole breast radi-
ation is a common mode of treatment for breast cancer,
and is equivalent to mastectomy in the treatment of early
stage disease [1,2]. Radiation has no detrimental effects
on breast cancer survival and, as recently reported, may
actually increase survival when given optimally in accor-
dance with modern dose and target recommendations
[3]. Nevertheless, radiation has been reported in several
studies to increase the risk of second non-breast malig-
nancies, including leukemia, sarcoma, lung cancer, and
esophageal cancer. In one report comparing breast cancer
patients who received radiation therapy after surgery
with those who did not, the relative risks of lung cancer
and myeloid leukemia were 1.62 and 2.99, respectively
[4]. The development of these second malignancies is
influenced by patient factors such as age, tobacco use,
and history of adjuvant systemic therapy [5,6].
Radiation-induced nonmelanoma skin cancer (NMSC)
was first reported seven years after the discovery of X-
rays [7]. Despite this long established relationship, NMSC
is not consistently included in studies evaluating second
non-breast malignancies that follow conservative surgery
and radiation for breast cancer. We present the case of a
woman who developed squamous cell carcinoma (SCC)
of the nipple nine years after conservative surgery and
radiation for ductal carcinoma in situ (DCIS) of the ipsi-
lateral breast.
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In December 2007, a 66-year-old African-American
woman with a past medical history significant for diabe-
tes mellitus, hypertension, congestive heart failure, and
fibroids presented to the Temple University Hospital,
Philadelphia with a non-healing ulcer of the right nipple.
The patient’s past medical history was also significant for
right breast DCIS for which she had undergone lumpec-
tomy and whole breast radiation therapy in February
1998. These interventions were followed by five years of
tamoxifen therapy. By mammography, the DCIS lesion
measured three centimeters and was located six centime-
ters from the nipple in the inferomedial quadrant of the
right breast. At lumpectomy, the lesion was a nuclear
grade II/III micropapillary tumor with apocrine features
(Figure 1). The margins of the specimen were negative for
tumor.
Our patient received a standard course of radiation.
Over 34 days, the right breast was treated with 6 Mv pho-
tons to a dose of 5000 cGy using medial and lateral tan-
gential fields measuring 16 × 22 cm. Fifteen degree
wedges were used to enhance dosimetry. The daily frac-
tion size was 200 cGy. Over four days, the area of resec-
tion was boosted an additional 1000 cGy using an en face
16 MeV electron field measuring 12 × 5 cm. The total
dose of radiation was 6000 cGy.
Nine years after surgery and radiation, our patient pre-
sented with a non-healing ulcer of the right nipple (Figure
2). The lesion was an irregularly shaped excoriation that
partially eroded through the nipple. There was both
serous and bloody discharge. The surrounding nipple-
areolar tissue was effaced, retracted, and indurated.
There was no odor or cellulitis. She stated she had been
suffering from a "raw" right nipple with intermittent heal-
ing for approximately two years.
There were no other significant physical exam findings,
including no palpable axillary lymphadenopathy. Mam-
mography and magnetic resonance imaging studies were
negative for recurrent breast cancer. However, the latter
demonstrated abnormal enhancement in the nipple-areo-
lar region.
An incisional biopsy of the lesion demonstrated inva-
sive SCC. Subsequently, our patient underwent wide exci-
sion of the nipple-areolar complex. Pathologically, the
lesion measured 15 mm (length) × 14 mm (width) × 9
mm (depth) and was characterized as a moderately to
poorly differentiated invasive SCC (Figure 3). Immuno-
histochemical staining was positive for CK903 (Figure 4),
CK5/6, p63 (Figure 5), and calponin and negative for
estrogen and progesterone receptors as well as Her-2/
neu, supporting a diagnosis of SCC. The resection mar-
gins were free of tumor and there was no evidence of lym-
phovascular invasion. The tumor was staged T1N0M0
(Stage 1).
Our patient was felt to be at high risk for recurrence
according to the National Comprehensive Cancer Net-
work Clinical Practice Guidelines [8]. Specifically, her
tumor occurred at the site of prior radiation therapy and
had poorly defined borders, a depth greater than 4 mm,
Figure 1 Right breast DCIS, micropapillary type.
Figure 2 Gross depiction of nipple ulcer.
Figure 3 Right breast moderately to poorly differentiated inva-
sive SCC.
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re-excision of the area was performed to ensure mini-
mum 10 mm margins were obtained. Sentinel lymph-
node biopsy was offered but our patient declined.
She was considered to have local disease and hence no
further treatment was recommended. She will have close
clinical follow-up biannually and mammography annu-
ally. She was also instructed to perform self skin and
lymph node exams.
Discussion
Multiple risk factors for SCC have been defined. The
most significant of these is solar radiation exposure. Mul-
tiple studies have shown the incidence of SCC increases
with proximity to the equator and cumulative sun expo-
sure [9]. Others risk factors include fair coloring, genetic
disorders of photosensitivity (e.g. xeroderma pigmento-
sum), chronic skin conditions (e.g. burn scars and venous
ulcers), impaired immunity, and exposures (e.g. arsenic
and radiation therapy).
Radiation therapy has also been described as a risk fac-
tor for SCC. In a report from the Childhood Cancer Sur-
vivor study, radiation therapy was associated with a 6.3
fold-increase in risk for NMSC (SCC and basal cell carci-
noma). Of these cancers 90% occurred within the radia-
tion field [10]. The association between radiation and
NMSC is also prevalent in the head and neck literature.
SCC subsequent to radiation therapy appears to be
more aggressive than that due to sunlight. In one study,
SCC arising in previously burned or irradiated skin was
associated with a five-year survival of only 52%. This was
in contrast to the 90% five-year survival observed in
patients with sunlight-induced SCC. Proposed explana-
tions of this difference included greater biologic aggres-
siveness of scar SCC, delayed presentation, and areas of
scarring being immunologically privileged sites [11].
Despite an extensive literature search, no reports of
SCC of the nipple following radiation therapy for breast
carcinoma were found. This result is surprising given the
large number of patients undergoing radiation therapy
for breast cancer. Overall, SCC of the nipple is quite rare,
likely because the area is not a sun-exposed region of the
body.
Multiple technical factors during radiation therapy for
breast cancer influence the risk of second malignancies.
These include quality, total dose, fractionation, degree of
overlap between the fields, tissue volume in the radiation
field, as well as the degree and quality of scatter outside
the radiation field [6,12]. The nipple is at significant risk
for exposure to toxic doses of radiation if it protrudes into
the radiation field unshielded by other tissue. In effect, it
may become a "hotspot". Furthermore, inconsistent posi-
tioning of the nipple places it at further risk for radiation
overexposure. Our patient has large, pendulous breasts,
making inconsistent positioning more likely. Exposure of
the normal nipple tissue to high doses of radiation may
result in radiodermatitis, a risk factor for SCC. Fortu-
nately, improvements in radiation technique over the last
decade have decreased the risk of overexposure to the
nipple and acute radiation skin toxicity [13].
It is important to keep in mind that the absolute risk of
death from a second malignancy following radiation ther-
apy for breast cancer is less than 1% per year [6]. This risk
is much smaller than the survival benefit derived from
radiation therapy, which is about 6% at ten years [3].
SCC of the nipple should be included in the differential
diagnosis of a nipple lesion in a patient presenting after
radiation therapy. Other diagnoses to consider include
basal cell carcinoma, recurrent breast cancer, Paget's dis-
ease, and radiodermatitis.
Treatment options for SCC depend on the risk of recur-
rence and the presence of positive lymph nodes. Risk fac-
tors for recurrence include large diameter (≥20 mm on
the trunk and extremities, ≥10 mm on the cheeks, fore-
head, scalp, and neck, or ≥6 mm on the face, genitalia,
hands, and feet) poorly-defined borders, recurrence,
Figure 4 CK903 immunostaining of SCC.
Figure 5 p63 immunostaining of SCC.
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tion therapy or chronic inflammation, rapid growth, neu-
rologic symptoms, moderate or poor differentiation,
adenoid/adenosquamous/desmoplastic subtypes, greater
depth (Clark levels level IV/V or ≥4 mm), and perineural
or vascular involvement [8].
Patients without any of these risk factors are at low risk
for recurrence and may be treated with field therapies
such as curettage and electrodessication. Otherwise, both
low and high risk patients are treated surgically with
assessment of margins. Surgical options include standard
excision with post-operative margin assessment or Mohs
micrographic excision using frozen section. Margin ade-
quacy depends on recurrence risk status, size, and loca-
tion but generally falls between 4 mm and 10 mm.
Patients with positive lymph nodes, positive margins
after surgery, extensive nerve involvement, and those
who are not surgical candidates should be treated with
radiation therapy [8].
Conclusions
This case represents the first reported occurrence of SCC
of the nipple to follow conservative surgery and radiation
for DCIS of the ipsilateral breast. It is likely that radiation
overexposure resulted in a radiation burn and subsequent
radiodermatitis, placing it at risk for SCC. A diagnosis of
SCC should be considered in a patient with a nipple
lesion following radiation therapy for breast cancer.
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